96 related articles for article (PubMed ID: 17674274)
1. Clinical use of nitric oxide donors and L-arginine in obstetrics.
de Pace V; Chiossi G; Facchinetti F
J Matern Fetal Neonatal Med; 2007 Aug; 20(8):569-79. PubMed ID: 17674274
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and the biology of pregnancy.
Zullino S; Buzzella F; Simoncini T
Vascul Pharmacol; 2018 Nov; 110():71-74. PubMed ID: 30076925
[TBL] [Abstract][Full Text] [Related]
3. Outpatient cervical ripening before first-trimester surgical abortion: a comparison between misoprostol and isosorbide mononitrate.
Radulovic N; Norström A; Ekerhovd E
Acta Obstet Gynecol Scand; 2007; 86(3):344-8. PubMed ID: 17364311
[TBL] [Abstract][Full Text] [Related]
4. Cervical ripening after nitric oxide.
Norman JE; Thomson AJ; Greer IA
Hum Reprod; 1998 Feb; 13(2):251-2. PubMed ID: 9557815
[No Abstract] [Full Text] [Related]
5. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy.
Thomson AJ; Lunan CB; Ledingham M; Howat RC; Cameron IT; Greer IA; Norman JE
Lancet; 1998 Oct; 352(9134):1093-6. PubMed ID: 9798584
[TBL] [Abstract][Full Text] [Related]
6. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial.
Schmitz T; Fuchs F; Closset E; Rozenberg P; Winer N; Perrotin F; Verspyck E; Azria E; Carbonne B; Lepercq J; Maillard F; Goffinet F;
Obstet Gynecol; 2014 Dec; 124(6):1089-1097. PubMed ID: 25415159
[TBL] [Abstract][Full Text] [Related]
7. Potential efficacy of nitric oxide for cervical ripening in pregnancy at term.
Chanrachakul B; Herabutya Y; Punyavachira P
Int J Gynaecol Obstet; 2000 Dec; 71(3):217-9. PubMed ID: 11102606
[No Abstract] [Full Text] [Related]
8. Intracervical application of the nitric oxide donor isosorbide dinitrate for induction of cervical ripening: a randomised controlled trial to determine clinical efficacy and safety prior to first trimester surgical evacuation of retained products of conception.
Arteaga-Troncoso G; Villegas-Alvarado A; Belmont-Gomez A; Martinez-Herrera FJ; Villagrana-Zesati R; Guerra-Infante F
BJOG; 2005 Dec; 112(12):1615-9. PubMed ID: 16305563
[TBL] [Abstract][Full Text] [Related]
9. Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study.
Bullarbo M; Orrskog ME; Andersch B; Granström L; Norström A; Ekerhovd E
Am J Obstet Gynecol; 2007 Jan; 196(1):50.e1-5. PubMed ID: 17240231
[TBL] [Abstract][Full Text] [Related]
10. Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics.
Nicoll AE; Mackenzie F; Greer IA; Norman JE
Am J Obstet Gynecol; 2001 Apr; 184(5):958-64. PubMed ID: 11303205
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide in the human uterine cervix: endogenous ripening factor.
Väisänen-Tommiska MR
Ann Med; 2008; 40(1):45-55. PubMed ID: 18246474
[TBL] [Abstract][Full Text] [Related]
12. Isosorbide dinitrate for treatment of preterm labor.
Haghighi L; Akbarian A
Int J Gynaecol Obstet; 2005 Jun; 89(3):274-5. PubMed ID: 15919396
[No Abstract] [Full Text] [Related]
13. Nitric oxide donor isosorbide mononitrate for pre-induction cervical ripening at 41 weeks' gestation: A randomized controlled trial.
Rameez MF; Goonewardene IM
J Obstet Gynaecol Res; 2007 Aug; 33(4):452-6. PubMed ID: 17688611
[TBL] [Abstract][Full Text] [Related]
14. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial.
Sanu O
Obstet Gynecol; 2015 Mar; 125(3):741-742. PubMed ID: 25730246
[No Abstract] [Full Text] [Related]
15. Ultrasound evaluation of intrauterine growth restriction therapy by a nitric oxide donor (L-arginine).
Sieroszewski P; Suzin J; Karowicz-Bilińska A
J Matern Fetal Neonatal Med; 2004 Jun; 15(6):363-6. PubMed ID: 15280105
[TBL] [Abstract][Full Text] [Related]
16. Serum profile of isosorbide mononitrate after vaginal administration in the third trimester.
Bates CD; Nicoll AE; Mullen AB; Mackenzie F; Thomson AJ; Norman JE
BJOG; 2003 Jan; 110(1):64-7. PubMed ID: 12504938
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience of long-term transdermal treatment with nitric oxide donor for women with preeclampsia.
Nakatsuka M; Tada K; Kimura Y; Asagiri K; Kamada Y; Takata M; Nakata T; Inoue N; Kudo T
Gynecol Obstet Invest; 1999; 47(1):13-9. PubMed ID: 9852386
[TBL] [Abstract][Full Text] [Related]
18. [Effect and mechanism of L-arginine therapy for fetal growth retardation due to pregnancy-induced hypertension].
Zhang N; Xiong AH; Xiao X; Li LP
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):198-200. PubMed ID: 17355936
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide induced cervical ripening in the human: Involvement of cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin E(2).
Ekerhovd E; Weijdegård B; Brännström M; Mattsby-Baltzer I; Norström A
Am J Obstet Gynecol; 2002 Apr; 186(4):745-50. PubMed ID: 11967501
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide inhibits uterine contractility during pregnancy but not during delivery.
Yallampalli C; Garfield RE; Byam-Smith M
Endocrinology; 1993 Oct; 133(4):1899-902. PubMed ID: 8404632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
